ABC
VRTX icon

Associated Banc-Corp’s Vertex Pharmaceuticals VRTX Stock Holding History

Associated Banc-Corp’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.37M Sell
6,791
-24
-0.4% -$10.6K 0.08% 139
2026
Q1 		$3.04M Sell
6,815
-132
-2% -$61.6K 0.08% 138
2025
Q4 		$3.15M Sell
6,947
-171
-2% -$73.7K 0.08% 135
2025
Q3 		$2.79M Sell
7,118
-465
-6% -$194K 0.07% 148
2025
Q2 		$3.38M Sell
7,583
-580
-7% -$267K 0.1% 137
2025
Q1 		$3.96M Sell
8,163
-665
-8% -$310K 0.12% 129
2024
Q4 		$3.56M Sell
8,828
-291
-3% -$135K 0.11% 133
2024
Q3 		$4.24M Sell
9,119
-362
-4% -$174K 0.12% 128
2024
Q2 		$4.44M Sell
9,481
-143
-1% -$62.1K 0.14% 122
2024
Q1 		$4.02M Sell
9,624
-131
-1% -$55.4K 0.13% 128
2023
Q4 		$3.97M Sell
9,755
-99
-1% -$36.6K 0.14% 127
2023
Q3 		$3.43M Sell
9,854
-48
-0.5% -$16.8K 0.13% 129
2023
Q2 		$3.48M Buy
9,902
+5
+0.1% +$1.69K 0.13% 130
2023
Q1 		$3.12M Sell
9,897
-807
-8% -$242K 0.13% 134
2022
Q4 		$3.09M Sell
10,704
-202
-2% -$61.6K 0.13% 131
2022
Q3 		$3.16M Sell
10,906
-121
-1% -$34.8K 0.15% 128
2022
Q2 		$3.11M Sell
11,027
-448
-4% -$120K 0.14% 128
2022
Q1 		$3M Sell
11,475
-9,122
-44% -$2.16M 0.12% 138
2021
Q4 		$4.52M Sell
20,597
-5,480
-21% -$1.07M 0.17% 117
2021
Q3 		$4.73M Sell
26,077
-3,982
-13% -$777K 0.19% 112
2021
Q2 		$6.06M Buy
30,059
+22,225
+284% +$4.65M 0.24% 101
2021
Q1 		$1.86M Sell
7,834
-65,697
-89% -$14.4M 0.12% 132
2020
Q4 		$17.4M Buy
73,531
+32,417
+79% +$7.44M 0.68% 43
2020
Q3 		$11.2M Buy
41,114
+23,680
+136% +$6.53M 0.48% 55
2020
Q2 		$5.06M Buy
17,434
+9,595
+122% +$2.6M 0.23% 103
2020
Q1 		$1.86M Buy
+7,839
New +$1.8M 0.1% 155

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Associated Banc-Corp's VRTX Position: Q2 2026 in Review

Associated Banc-Corp reduced its Vertex Pharmaceuticals (VRTX) stake by 0.35% in Q2 2026, selling an estimated $10.6K and leaving 6,791 shares worth $3.37M. The position accounts for 0.08% of the portfolio, ranked #139.

Associated Banc-Corp first reported a position in VRTX in Q1 2020 and has held it in 26 quarters since. The position peaked at $17.4M in Q4 2020. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Associated Banc-Corp held 6,791 shares of Vertex Pharmaceuticals worth $3.37M as of Q2 2026.
  • Associated Banc-Corp sold 24 Vertex Pharmaceuticals shares in Q2 2026, an estimated $10.6K.
  • Vertex Pharmaceuticals made up 0.08% of Associated Banc-Corp's portfolio in Q2 2026, its #139 holding.
  • Associated Banc-Corp first reported a position in Vertex Pharmaceuticals in Q1 2020 and has held it in 26 quarters since.
  • Associated Banc-Corp's Vertex Pharmaceuticals position peaked at $17.4M in Q4 2020.
  • 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Associated Banc-Corp's 13F filing for Q2 2026, filed 31 Jul 2026.